The U.S. Department of Health and Human Services (HHS) is re-evaluating its stance on fluoride in drinking water by reconvening the Community Preventive Services Task Force, an independent panel of health experts. This move follows Health Secretary Robert F. Kennedy Jr.’s recent statement in Salt Lake City, indicating plans to halt the Centers for Disease Control and Prevention’s recommendation for community water fluoridation.
Fluoride, commonly added to public water supplies to prevent tooth decay, has been a controversial topic for decades. While the American Dental Association continues to support fluoridation as an effective dental health measure, concerns about potential health risks have gained traction.
The Environmental Protection Agency (EPA) will also review new scientific data on fluoride’s health effects. EPA Administrator Lee Zeldin confirmed that this effort is in collaboration with HHS, with the goal of re-evaluating the agency’s current enforceable fluoride limit of 4.0 milligrams per liter (mg/L). Currently, the U.S. Public Health Service recommends maintaining levels below 0.7 mg/L. Studies show that exposure above 1.5 mg/L can increase risks of bone fractures, thyroid dysfunction, and neurological damage.
In a landmark move, Utah became the first state to ban fluoride in public water systems after Governor Spencer Cox signed new legislation last month. The decision faced strong opposition from health experts and organizations, including the American Dental Association.
As of 2022, about 63% of Americans receive fluoridated water through their municipal systems. A 2024 federal court ruling ordered the EPA to tighten its standards, citing unacceptable health risks to children under current fluoride levels. While Kennedy claims links between fluoride and conditions like cancer, his statements remain unsubstantiated by definitive scientific evidence.


Kristi Noem Ends Western Hemisphere Tour in Diminished Role After DHS Firing
G7 Foreign Ministers Gather in France Amid Global Tensions and U.S. Policy Uncertainty
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Denmark Election 2026: Frederiksen Eyes Third Term Amid Trump-Greenland Tensions
Iran-U.S. Negotiations: Tehran Reviews American Peace Proposal Amid Ongoing Gulf Conflict
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
US-Iran Ceasefire Talks Underway: What You Need to Know
Trump's Overhaul of American History: Museums, Monuments, and Cultural Institutions
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Iran Demands Lebanon Be Part of Any Ceasefire Deal With Israel and the U.S.
Trump to Visit China in May for High-Stakes Xi Summit Amid Iran War
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Trump Administration Opens Two New Investigations Into Harvard Over Discrimination and Antisemitism
Russia Strikes Kharkiv and Izmail as Cross-Border Drone War Escalates
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 



